|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A brief review on: Butea monosperma |
| Authors Name: | PRABHA HULLATTI , AYESHA TABASSUM , SHRAVYA SOODA , SAI KEERTHANA P.B. , SHIVAKUMAR PATIL |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_204293
|
| Published Paper Id: | IJNRD2308427 |
| Published In: | Volume 8 Issue 8, August-2023 |
| DOI: | |
| Abstract: | The 17% of rural population were depending on traditional based components and were using for various treatment of disorders. In present scenario the synthetic analogues lead abundant, drastic tragedies exhibits who are consuming the analogues, especially chemotherapeutic analogues over elicits more severe adverse effects rather than clinical value. The developed countries like Japan so far not depending on allopathic medicine because of genomic alterations and leads defect on immunity. By considering all these facts we decided that, bio analogues are excellent, safe, economically cheap and comfortable for human kinds hence the present study is focused on a brief review on butea monosperma. |
| Keywords: | Butea monosperma, Antioxidant, DPPH, Antimicrobial. |
| Cite Article: | "A brief review on: Butea monosperma", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 8, page no.e292-e299, August-2023, Available :http://www.ijnrd.org/papers/IJNRD2308427.pdf |
| Downloads: | 000118765 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2308427 Registration ID: 204293 Published In: Volume 8 Issue 8, August-2023 DOI (Digital Object Identifier): Page No: e292-e299 Country: DAVANGERE, KARNATAKA, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2308427 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2308427 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn